1.
Lee H, Duggan P, Neri EP, Tay J, Zepeda VJ. Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance. Mediterr J Hematol Infect Dis [Internet]. 2019Jan.1 [cited 2020Jul.4];11(1):e2019007. Available from: https://mjhid.org/index.php/mjhid/article/view/2019.007